Peptides in Ireland: BPC-157, Reta, TB-500, GHK-Cu

Research peptides in the Irish context

Baltic BioLabs is an independent research peptide shop. The Irish research community works with peptides inside a well-defined frame: the HPRA's pharmaceutical regulation, Revenue Commissioners' customs treatment, and membership of the EU customs union and single market. What follows is the practical side of that: where each compound stands, what a batch certificate has to show, and how the price per milligram actually compares.

Irish regulatory framework

The Health Products Regulatory Authority (HPRA) oversees medicines in Ireland. Its classification guidance considers both presentation and pharmacological, immunological or metabolic function. A research label, absence of human dosing or lack of marketing authorisation does not alone exclude a product from medicines rules. Authorised finished medicines and a supplier’s laboratory material must be assessed as different offers; verify the exact product, customer group and intended work. Further reading: Health Products Regulatory Authority (HPRA)

EU single-market advantage for Irish researchers

Ordinary Union goods moving between Member States within the common customs and VAT territory do not require a third-country import procedure or import duties. Product-specific controls and medicines restrictions remain possible. Confirm the actual dispatch location, eligible destination and delivery window with the selected supplier. Some shipments to Ireland are currently experiencing delays of 10 days or longer. Allow additional time and confirm the latest delivery estimate with the supplier before ordering. Further reading: legal information

Compounds worth knowing

The linked catalogue and guides cover several research contexts: tissue models involving BPC-157 and TB-500, skin/connective-tissue contexts for GHK-Cu, and Epitalon in ageing-related preclinical literature. This is an orientation to the site’s selection, not a ranking of research prevalence or evidence that a commercial combination was studied as supplied. Read the exact material and model in the original study before relating an offered reagent to its results. Further reading: TB-500: offered material and documents · research index

Quality criteria for reproducible work

The required specification depends on the experiment. A universal HPLC minimum of 99% is not an international research rule. A primary investigation of synthetic research-peptide quality illustrates the need for independent, method-specific verification. Check identity, content, relevant impurities, method, batch and manufacturer against the project specification. The lab reports section publishes available reports for direct inspection. Peptide-purity reports are published only when the reported HPLC result is at least 99%; quantity-only or solvent reports are separate. Match the supplier, offered size and sample or batch reference before applying a result to an order.

Customs and VAT for non-EU shipments

For a third-country order, compare the price with the applicable VAT, customs duty and carrier charges, checking what the supplier collects at checkout. VAT and customs-duty relief are different rules.Revenue explains that the former €22 import-VAT relief ended on 1 July 2021. Its 2026 low-value customs guidance concerns the €150 customs-duty relief and a €3 charge for eligible online consumer consignments from 1 July 2026, not a new removal of VAT relief. Professional laboratory imports need assessment under the rules for their actual declaration and goods; do not transfer a consumer example to every business shipment.

Are peptides legal in Ireland?

It depends on the compound and on how it is sold, and those are two separate tests. A product is a medicine when it can restore, correct or modify physiological functions, and it is also a medicine when it is presented as having curative or preventive properties. The second test looks at the selling, not the molecule: a laboratory reagent offered with human dosing, weight-loss promises or cycle protocols becomes a medicine by presentation alone, whatever the label says.

HPRA reported 48,752 units claiming to be GLP-1 medicines detained in 2025, compared with 1,582 in 2024. Separately, its 13,898 detained consignments in 2025 cover all medicine categories, not GLP-1 alone. These are enforcement counts, not the proportion of laboratory shipments stopped. See the HPRA 2025 enforcement report.

• Is BPC-157 legal in Ireland? BPC-157 is not presented here as an authorised finished medicine. A laboratory label or absence of medical claims does not decide medicine classification or import eligibility; assess presentation, function and the concrete offered material.
• Is TB-500 legal in Ireland? A TB-500 trade name does not itself establish marketing authorisation or legal eligibility. Worth knowing separately: two different products are sold under that one name, the seven-residue fragment LKKTETQ and full thymosin beta-4 at 43 amino acids. Do not infer an identical legal position from a shared trade name. Check the supplier’s declared material and the actual identity test before applying findings from a named study.
• Is GHK-Cu legal in Ireland? A GHK-Cu ingredient name does not itself establish medicine classification or permission to import. Cosmetic formulations and laboratory materials have different intended purposes and product-specific requirements; an ingredient name alone does not approve a finished cosmetic. A lyophilised laboratory vial is not a cosmetic product.
• Is retatrutide legal in Ireland? Retatrutide holds no marketing authorisation as a finished medicine; this is not an import permission. It does not exist in the pharmacy channel, and an unapproved laboratory offer is not an authorised prescription medicine. That authorised GLP-1 medicines exist in the same drug class gives retatrutide no status of its own.
• Semaglutide and tirzepatide are active ingredients in authorised prescription medicines dispensed through pharmacies. Approval of a particular finished medicine does not authorise every laboratory vial sharing its ingredient name. The detention figures above concern products claiming to be GLP-1 medicines, not those two ingredients alone.

Marketing authorisation evaluates a particular medicinal product; its absence is not proof that no laboratory or authority has ever examined any material sharing the compound name. For a supplier’s reagent, inspect the offered variant and matching batch report, including methods and scope. A COA does not substitute for medicines authorisation, clinical safety evidence or import eligibility. Further reading: HPRA enforcement and peptide imports · legal information

GHK-Cu: cosmetic and laboratory contexts

This section separates the cosmetic and laboratory contexts of GHK-Cu within the site’s catalogue without making a claim about the frequency of Irish searches. It is a defined complex between the tripeptide glycyl-histidyl-lysine and a copper ion; the copper is part of the structure rather than an additive. It appears in two contexts that follow different rules: as a cosmetic ingredient in topical formulations, and as a lyophilised reagent for laboratory use. An ingredient name does not establish the authorisation or classification of a particular finished product.

The same distinction between substance and presentation applies here too, and it is why "copper peptide" as a generic term is not a synonym for GHK-Cu. The product page is GHK-Cu, alongside BPC-157, TB-500 and Epitalon.

Retatrutide ("reta"): receptor targets and batch comparison

"Reta" is a shorthand used here for retatrutide; both forms refer to the same compound. The page does not measure which spelling Irish researchers use more often. Retatrutide (LY3437943) is a triple agonist: it acts on the GLP-1, GIP and glucagon receptors at once. Receptor targets are one mechanistic distinction from its better known relatives, not the whole pharmacological or regulatory comparison. Semaglutide acts on one, tirzepatide on two, retatrutide on three.

Retatrutide is investigational and has no EU marketing authorisation; the linked laboratory offer is not an authorised finished medicine. Compare laboratory offers by declared material, vial size, matching batch documentation and price per milligram. A pharmacy medicine’s price is not a like-for-like comparator for a research vial.

A reported HPLC percentage is method-dependent and does not establish the identity of the material by itself. Compare the actual identity method and result, content and relevant impurity tests in the matching report. Different substances cannot reliably be identified by the appearance of a powder. Substitution is a possible issue to investigate, not a measured prevalence claim on this page.

Goods already in free circulation moving from another EU Member State within the EU VAT territory to Ireland do not undergo ordinary third-country import clearance. Seller VAT, delivery charges and product controls are separate. Some Irish shipments are taking 10 days or longer; confirm the supplier’s current estimate. Vial sizes, price per milligram and available batch documents are on retatrutide price in Ireland.

Price per milligram, not price per vial

Different vial sizes make published prices incomparable. The one calculation that makes them comparable is price divided by the milligrams in the vial. A worked example with invented figures: a 10 mg vial at 60 euro costs 6 euro per milligram, while a 5 mg vial at 35 euro costs 7. The larger vial is cheaper per milligram in this example; calculate the actual offers rather than assume a general size discount.

Compare the same declared material and formulation, and include shipping and any applicable taxes in the payable total. Storage and solution stability depend on the compound, formulation and conditions; do not use a biological half-life as a vial-expiry rule. An analytical report provides evidence about its identified sample, not every vial automatically. The supplier checks are on buying research peptides in Ireland.

What a certificate of analysis actually shows

Our lab reports section publishes 47 certificates openly, issued by independent laboratories rather than by the manufacturer. The scope varies by report. Two different measurements to look for, where provided, are:

• Purity as a percentage: a method-dependent result, such as HPLC area, that does not alone establish mass fraction, identity or sterility.
• Content in milligrams, measured against the label. A vial can be pure and underfilled at the same time.

An identity test can help distinguish materials only within its documented method and scope; the report must actually match the offered batch. Do not infer that every GLP-1 report used a blind test against all three compounds. This page provides no market prevalence of substitutions. Batch numbers, method, result and issuer make the evidence assessable, rather than the trade name alone. Further reading: BPC-157 in Ireland · retatrutide in Ireland

Frequently asked questions

Can you buy research peptides in Ireland? Whether a particular order is permitted depends on the material, its presentation and function, the supplier’s customer rules and the destination requirements. A research label and absence of dosing instructions do not alone remove medicines rules. Check the supplier’s terms and the HPRA classification guidance for the actual offered product. Further reading: peptides Ireland: the basics

Is BPC-157 legal in Ireland? It has no marketing authorisation in the EU and is offered here as a research reagent. That does not decide the classification or eligibility of a particular order. Separately, BPC-157 is explicitly named in class S0 of the WADA Prohibited List, prohibited at all times in sport.

Where can I buy reta in Ireland? "Reta" is used here as a shorthand for retatrutide. The linked guide compares offered sizes, price per milligram and available batch documents. Verify the selected supplier’s actual dispatch country, customer eligibility and delivery terms; neither the shorthand nor an EU address determines legality or delivery. Further reading: retatrutide in Ireland

How much is reta in Ireland? The 10mg vial is €62.99 (€6.30 per mg). Sizes run from €40.99 for 5mg to €212.99 for 50mg; the lowest price per milligram is the 30mg vial at €4.00 per mg. Prices checked 3 November 2026. Each size names its supplier and discount code on the product page, and the final price, with delivery to Ireland, is shown in that supplier’s checkout. Every size and price: retatrutide price in Ireland

How do I get peptides in Ireland? Select the offered material and vial size on the product page, then inspect the named supplier’s checkout and permitted customer group. Baltic Peptides (code balticbiolabs10) and Particle Peptides (code BALTIC10) are the linked suppliers, and CertaPeptides (code AFF-BALTICBIOLAB) for most retatrutide sizes; confirm the current discount, destination eligibility and delivery conditions there. A seller is not automatically a laboratory or manufacturer, and EU dispatch does not guarantee a delivery time or exemption from product controls. Some shipments to Ireland are currently experiencing delays of 10 days or longer; confirm the latest estimate before ordering. Further reading: buying peptides in Ireland

Is GHK-Cu legal in Ireland? A laboratory material and a topical cosmetic are different product offers, even when the same ingredient name appears. Check the intended purpose and the requirements for the finished product; the ingredient name or research label alone is not a medicine-classification decision or permission to sell, import or use it.

Does a parcel from another EU country go through customs? Ordinary goods already in free circulation within the EU customs and VAT territory do not require third-country import clearance or import VAT at the Irish border. Dispatch from an EU address alone does not establish that status. Seller VAT and product-specific controls remain separate questions.

What happens if a shipment is queried? Follow the relevant authority’s request and deadline, providing the requested invoice and any matching analytical or product documents. Complete paperwork supports an assessment but does not guarantee release or replace a required authorisation. The rule depends on the actual goods and import case.

Informational page in a research context. Full frame in the disclaimer.